Role of exosomes in treatment of hepatocellular carcinoma

Demetrios Moris, Eliza W. Beal, Jeffery Chakedis, Richard Burkhart, Carl Schmidt, Mary Dillhoff, Xufeng Zhang, Stamatios Theocharis, Timothy M. Pawlik

Research output: Contribution to journalReview article

Abstract

Exosomes are nanovesicles that may play a role in intercellular communication by acting as carriers of functional contents such as proteins, lipids, RNA molecules and circulating DNA from donor to recipient cells. In addition, exosomes may play a potential role in immunosurveillance and tumor pathogenesis and progression. Recently, research has increasingly focused on the role of exosomes in hepatocellular carcinoma (HCC), the most common primary liver malignancy. We herein review data on emerging experimental and clinical studies focused on the role of exosomes in the pathogenesis, diagnosis, progression and chemotherapy response of patients with HCC. Beyond their diagnostic value in HCC, exosomes are involved in different mechanisms of HCC tumor pathogenesis and progression including angiogenesis and immune escape. Moreover, exosomes have been demonstrated to change the tumor microenvironment to a less tolerogenic state, favoring immune response and tumor suppression. These results underline a practical and potentially feasible role of exosomes in the treatment of patients with HCC, both as a target and a vehicle for drug design. Future studies will need to further elucidate the exact role and reliability of exosomes as screening, diagnostic and treatment targets in patients with HCC.

Original languageEnglish (US)
Pages (from-to)219-228
Number of pages10
JournalSurgical Oncology
Volume26
Issue number3
DOIs
StatePublished - Sep 1 2017

Fingerprint

Exosomes
Hepatocellular Carcinoma
Therapeutics
Neoplasms
Immunologic Monitoring
Tumor Microenvironment
Drug Design
Tissue Donors
RNA
Lipids
Drug Therapy
Liver
DNA

Keywords

  • Biomarkers
  • Cirrhosis
  • Exosomes
  • Hepatitis
  • Hepatocellular carcinoma
  • Liver
  • miRNA
  • Therapy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Moris, D., Beal, E. W., Chakedis, J., Burkhart, R., Schmidt, C., Dillhoff, M., ... Pawlik, T. M. (2017). Role of exosomes in treatment of hepatocellular carcinoma. Surgical Oncology, 26(3), 219-228. https://doi.org/10.1016/j.suronc.2017.04.005

Role of exosomes in treatment of hepatocellular carcinoma. / Moris, Demetrios; Beal, Eliza W.; Chakedis, Jeffery; Burkhart, Richard; Schmidt, Carl; Dillhoff, Mary; Zhang, Xufeng; Theocharis, Stamatios; Pawlik, Timothy M.

In: Surgical Oncology, Vol. 26, No. 3, 01.09.2017, p. 219-228.

Research output: Contribution to journalReview article

Moris, D, Beal, EW, Chakedis, J, Burkhart, R, Schmidt, C, Dillhoff, M, Zhang, X, Theocharis, S & Pawlik, TM 2017, 'Role of exosomes in treatment of hepatocellular carcinoma', Surgical Oncology, vol. 26, no. 3, pp. 219-228. https://doi.org/10.1016/j.suronc.2017.04.005
Moris D, Beal EW, Chakedis J, Burkhart R, Schmidt C, Dillhoff M et al. Role of exosomes in treatment of hepatocellular carcinoma. Surgical Oncology. 2017 Sep 1;26(3):219-228. https://doi.org/10.1016/j.suronc.2017.04.005
Moris, Demetrios ; Beal, Eliza W. ; Chakedis, Jeffery ; Burkhart, Richard ; Schmidt, Carl ; Dillhoff, Mary ; Zhang, Xufeng ; Theocharis, Stamatios ; Pawlik, Timothy M. / Role of exosomes in treatment of hepatocellular carcinoma. In: Surgical Oncology. 2017 ; Vol. 26, No. 3. pp. 219-228.
@article{8740c457d2e6405e97230dfaa34992a1,
title = "Role of exosomes in treatment of hepatocellular carcinoma",
abstract = "Exosomes are nanovesicles that may play a role in intercellular communication by acting as carriers of functional contents such as proteins, lipids, RNA molecules and circulating DNA from donor to recipient cells. In addition, exosomes may play a potential role in immunosurveillance and tumor pathogenesis and progression. Recently, research has increasingly focused on the role of exosomes in hepatocellular carcinoma (HCC), the most common primary liver malignancy. We herein review data on emerging experimental and clinical studies focused on the role of exosomes in the pathogenesis, diagnosis, progression and chemotherapy response of patients with HCC. Beyond their diagnostic value in HCC, exosomes are involved in different mechanisms of HCC tumor pathogenesis and progression including angiogenesis and immune escape. Moreover, exosomes have been demonstrated to change the tumor microenvironment to a less tolerogenic state, favoring immune response and tumor suppression. These results underline a practical and potentially feasible role of exosomes in the treatment of patients with HCC, both as a target and a vehicle for drug design. Future studies will need to further elucidate the exact role and reliability of exosomes as screening, diagnostic and treatment targets in patients with HCC.",
keywords = "Biomarkers, Cirrhosis, Exosomes, Hepatitis, Hepatocellular carcinoma, Liver, miRNA, Therapy",
author = "Demetrios Moris and Beal, {Eliza W.} and Jeffery Chakedis and Richard Burkhart and Carl Schmidt and Mary Dillhoff and Xufeng Zhang and Stamatios Theocharis and Pawlik, {Timothy M.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.suronc.2017.04.005",
language = "English (US)",
volume = "26",
pages = "219--228",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Role of exosomes in treatment of hepatocellular carcinoma

AU - Moris, Demetrios

AU - Beal, Eliza W.

AU - Chakedis, Jeffery

AU - Burkhart, Richard

AU - Schmidt, Carl

AU - Dillhoff, Mary

AU - Zhang, Xufeng

AU - Theocharis, Stamatios

AU - Pawlik, Timothy M.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Exosomes are nanovesicles that may play a role in intercellular communication by acting as carriers of functional contents such as proteins, lipids, RNA molecules and circulating DNA from donor to recipient cells. In addition, exosomes may play a potential role in immunosurveillance and tumor pathogenesis and progression. Recently, research has increasingly focused on the role of exosomes in hepatocellular carcinoma (HCC), the most common primary liver malignancy. We herein review data on emerging experimental and clinical studies focused on the role of exosomes in the pathogenesis, diagnosis, progression and chemotherapy response of patients with HCC. Beyond their diagnostic value in HCC, exosomes are involved in different mechanisms of HCC tumor pathogenesis and progression including angiogenesis and immune escape. Moreover, exosomes have been demonstrated to change the tumor microenvironment to a less tolerogenic state, favoring immune response and tumor suppression. These results underline a practical and potentially feasible role of exosomes in the treatment of patients with HCC, both as a target and a vehicle for drug design. Future studies will need to further elucidate the exact role and reliability of exosomes as screening, diagnostic and treatment targets in patients with HCC.

AB - Exosomes are nanovesicles that may play a role in intercellular communication by acting as carriers of functional contents such as proteins, lipids, RNA molecules and circulating DNA from donor to recipient cells. In addition, exosomes may play a potential role in immunosurveillance and tumor pathogenesis and progression. Recently, research has increasingly focused on the role of exosomes in hepatocellular carcinoma (HCC), the most common primary liver malignancy. We herein review data on emerging experimental and clinical studies focused on the role of exosomes in the pathogenesis, diagnosis, progression and chemotherapy response of patients with HCC. Beyond their diagnostic value in HCC, exosomes are involved in different mechanisms of HCC tumor pathogenesis and progression including angiogenesis and immune escape. Moreover, exosomes have been demonstrated to change the tumor microenvironment to a less tolerogenic state, favoring immune response and tumor suppression. These results underline a practical and potentially feasible role of exosomes in the treatment of patients with HCC, both as a target and a vehicle for drug design. Future studies will need to further elucidate the exact role and reliability of exosomes as screening, diagnostic and treatment targets in patients with HCC.

KW - Biomarkers

KW - Cirrhosis

KW - Exosomes

KW - Hepatitis

KW - Hepatocellular carcinoma

KW - Liver

KW - miRNA

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=85018296423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018296423&partnerID=8YFLogxK

U2 - 10.1016/j.suronc.2017.04.005

DO - 10.1016/j.suronc.2017.04.005

M3 - Review article

C2 - 28807240

AN - SCOPUS:85018296423

VL - 26

SP - 219

EP - 228

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 3

ER -